|
Matthew Hantzmon is a senior executive with a successful record in medical technology and renewable energy start-up companies. Mr. Hantzmon is currently Vice President of Business Development for Diffusion, responsible for strategic partnerships and investor relations. Prior to joining Diffusion, Mr. Hantzmon was Managing Director of Greenlight Energy, Inc., an independent power producer focused on wind energy projects. He was with Greenlight from 2001 until 2006 when the company was sold to British Petroleum (BP). Mr. Hantzmon was a co-founder and President of GeNeuron Therapeutics, Inc., a biotechnology company, which developed biologically enhanced medical devices for the treatment of neurovascular diseases. Prior to founding GeNeuron, Mr. Hantzmon was Director of International Market Development for Varian Medical Systems. In this role, he was responsible for marketing, sales, and business development for all geographies outside North America. Prior to its acquisition by Varian in 1999, he had been Vice President and COO at Multimedia Medical Systems, Inc., a biotechnology company focusing on radiation treatment planning systems. Other roles as a founding member of MMS included Secretary, Treasurer and Chief Financial Officer. In his early career, Mr. Hantzmon was a Senior Financial Analyst for IBM and a Management Consultant for Price Waterhouse, LLC. He is a founder and board member of Columbia Power Technologies, a development stage company focused on conversion of wave energy into electricity. Mr. Hantzmon holds a B.A. degree from the University of Virginia and an MBA from the Kellogg Graduate School of Management at Northwestern University. He is also a Certified Management Accountant. | 